New Zealand markets open in 8 hours 42 minutes

ApicHope Pharmaceutical Co., Ltd (300723.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
22.26-0.01 (-0.04%)
At close: 03:04PM CST

ApicHope Pharmaceutical Co., Ltd

No. 27, Yunrun Building
17th Floor Huanyu 1st Road Guangzhou International Biological Island, Huangpu
Guangzhou 510320
China
86 20 2887 7623
https://www.apichope.com

Sector(s)Healthcare
IndustryDrug Manufacturers - Specialty & Generic
Full-time employees1,676

Key executives

NameTitlePayExercisedYear born
Mr. Hanxiong LiChairman of the Board of Directors & GMN/AN/A1974
Mr. Huixing ZhangChief Financial OfficerN/AN/A1966
Ms. Dongling YangDeputy GM & Non-Independent DirectorN/AN/A1967
Mr. Mingyuan ZhangBoard SecretaryN/AN/A1985
Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

ApicHope Pharmaceutical Co., Ltd, together with its subsidiaries, engages in the research and development, production, and sale of pharmaceutical drugs. Its pediatric medicines include fuganlin and yiqi jianpi oral liquid, carboxymestrine oral solution, and xiaoer kechuanling oral liquid products; and clindamycin hydrochloride palmitate dispersible tablet, acetylguitaricin dry suspension, qinxiangqingjie oral liquid, levocetirizine hydrochloride drop, epstein hydrochloride granule, clindamycin hydrochloride palmitate granule, clindamycin hydrochloride for injection, clindamycin phosphate injection, ambroxol hydrochloride drop, montelukast sodium granule, acyclovir for injection, and oseltamivir phosphate capsule products. The company's chronic disease drugs comprise hepatocyte growth stimulating hormone and pentoxifylline for injections, kangshen granules, uqingshu granules, shenbai lotion products, compound monoammonium glycyrrhizinate S and lansoprazole for injections, houttuynia sodium tablets, omeprazole sodium and bromhexine hydrochloride for injections, huixinkang tablets, amlodipine benzenesulfonate dispersible tablets, yanhunin and sodium ferulate for injections, cyclic adenosine phosphate and ambroxol hydrochloride for injections, valsartan amlodipine tablets, and nifedipine controlled release tablets, as well as tricorutin, aceglutamide, vinpocetine, and doxofylline for injections. In addition, it offers compound xiangrui water, yinhuang oral liquid, and xiongdan chuanbei oral liquid products; venlafaxine hydrochloride sustained-release capsules; and levofloxacin hydrochloride, sodium ozagrel, brain protein hydrolysate, and ganciclovir for injections. The company was formerly known as Yipinhong Pharmaceutical Co.,Ltd and changed its name to ApicHope Pharmaceutical Co., Ltd in December 2021. ApicHope Pharmaceutical Co., Ltd was founded in 2002 and is based in Guangzhou, China.

Corporate governance

ApicHope Pharmaceutical Co., Ltd’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.